Tag: licensing
-
Biotech Licenses Natural Anti-Bacterial Compounds
AMRI, a biotechnology company in Albany, New York agreed to a research and licensing deal with Genentech, a Roche Group company, for AMRI’s anti-bacterial compounds from its natural products sample collection. Under the agreement, Genentech will receive an exclusive license to develop and commercialize potential products from AMRI’s anti-bacterial program. AMRI will also collaborate with…
-
Illinois Start Up Licenses Anti-Staph Infection Research
Start up company ImmuVen in Champaign, Illinois agreed to license new technology and processes for treating methicillin-resistant Staphylococcus aureus (MRSA) from University of Illinois in Urbana-Champaign. ImmuVen was founded by the technology’s inventors, microbiologists David Kranz of the University of Illinois Urbana-Champaign and Patrick Schlievert of the University of Minnesota in Minneapolis. MRSA is a…
-
Start Up Company Licenses University Polymer Research
A new start up company has licensed advanced polymers research at Case Western Reserve University in Cleveland, Ohio, aiming to commercialize polymer technology. PolymerPlus LLC, in nearby Valley View, plans to work with some of the intellectual property developed at the university’s Center for Layered Polymeric Systems (CLiPS). PolymerPlus will seek out specific applications for…
-
Collaboration Develops, Patents Fish Hatchery Vaccine
A team of researchers from University of Idaho in Moscow, Clear Springs Foods Inc. in Buhl, Idaho, and the Agricultural Research Service of USDA, have developed a coldwater disease (CWD) vaccine. CWD is a bacterial disease caused by Flavobacterium psychrophilum, and results in a lethal infection causing losses of hatchery-reared salmonids — e.g., salmon, trout,…
-
Univ. Develops, Licenses Nanotech Bone Injection Technology
A bone-healing fluid that can potentially be injected into breaks with a syringe has been licensed from Brown University in Providence, Rhode Island by a biotech startup for further development. The technology, still in an early stage, was developed by Brown engineering professor Thomas Webster, and licensed to Audax Medical Inc., based in Littleton, Massachusetts.…
-
Medical Implant Coating Made from Univ. Licensed Technology
The long-term performance of medical implant devices, like heart valves and cardiac stents, could be enhanced substantially by new bio-coating technology recently licensed to University of Alabama at Birmingham (UAB) spin-off company Endomimetics LLC. The patent-pending technology is a coating for implants, called bio-nanomatrix, made with a bio-engineered nanomaterial that mimics natural endothelium, the substance…
-
Start Up Licenses University Mining Sensor Technology
United Science, a start up company in Center City, Minnesota, has licensed sensor technology developed at the University of Minnesota in Minneapolis that could prevent toxic byproducts of copper and iron mining, and potentially other industries, from ending up in the environment. Chemistry associate professor Philippe Buhlmann developed the ion selective electrode (ISE) sensor membrane.…
-
Baxter, Takeda Complete Deal on Influenza Vaccines
Baxter International Inc. in Deerfield, Illinois and Takeda Pharmaceutical Company in Osaka, Japan said today they completed a development, license, and technology transfer agreement to bring Baxter’s Vero cell culture-based influenza vaccines to the Japanese market. This agreement expands on the companies’ current collaborations involving cell-based flu vaccines. Under the agreement, Baxter will exclusively license…
-
New Process Developed for Bio-Plastic Feedstocks
Chemical engineers at University of Massachusetts in Amherst have developed a way to produce high-volume chemical feedstocks from biomass, such as waste wood, agricultural waste and non-food energy crops. This method, that the authors say is economically competitive to current processes using fossil fuels, can produce industrial materials such as benzene, toluene, xylenes, and olefins,…
-
University Licenses Nanoparticle Drug Delivery Technology
The University of British Columbia (UBC) and the Centre for Drug Research and Development (CDRD), both in Vancouver, Canada, said today that Covidien, a Dublin, Ireland provider of health care products, has licensed a drug-delivery platform technology invented by UBC researcher, Pieter Cullis. CDRD provided the development facilities and commercialization services that led to this…